Sanctuary Advisors »

Galectin Therapeutics shares owned by Sanctuary Advisors

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Sanctuary Advisors from 13F filings

Historical chart of Sanctuary Advisors investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Sanctuary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Sanctuary Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $347k 101k 3.45

More positions owned by Sanctuary Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Total Usd (IUSB)
Exxon Mobil Corporation (XOM)

View all positions for Sanctuary Advisors

Top funds holding Galectin Therapeutics

Vanguard Group
BlackRock
Susquehanna International
Geode Capital Management
Commonwealth Equity Services
Sontag Advisory
Geneos Wealth Management
State Street Corporation
Morgan Stanley
Atria Wealth Solutions
Cutter & CO Brokerage
Cambridge Investment Research Advisors
Sanctuary Advisors
LPL Financial
Squarepoint Ops

View all funds holding Galectin Therapeutics